Patti, Giuseppe Rocco Salvatore
 Distribuzione geografica
Continente #
EU - Europa 9.630
AS - Asia 7.052
NA - Nord America 6.809
SA - Sud America 1.535
AF - Africa 387
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.434
Nazione #
US - Stati Uniti d'America 6.551
RU - Federazione Russa 3.481
IE - Irlanda 2.324
SG - Singapore 2.183
CN - Cina 1.461
HK - Hong Kong 1.276
BR - Brasile 1.153
VN - Vietnam 1.115
IT - Italia 896
UA - Ucraina 716
DE - Germania 529
FR - Francia 489
SE - Svezia 485
IN - India 195
GB - Regno Unito 178
BJ - Benin 170
AR - Argentina 145
KR - Corea 140
CA - Canada 131
BD - Bangladesh 90
ID - Indonesia 85
MX - Messico 83
NL - Olanda 82
PL - Polonia 81
ZA - Sudafrica 79
CZ - Repubblica Ceca 76
IQ - Iraq 74
JP - Giappone 68
AT - Austria 66
EC - Ecuador 63
TR - Turchia 63
FI - Finlandia 58
CO - Colombia 48
IR - Iran 40
ES - Italia 39
PK - Pakistan 37
MA - Marocco 30
VE - Venezuela 30
BE - Belgio 29
CL - Cile 29
LT - Lituania 28
PE - Perù 25
SA - Arabia Saudita 23
PY - Paraguay 22
PH - Filippine 21
KE - Kenya 20
MY - Malesia 20
EG - Egitto 17
TH - Thailandia 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
IL - Israele 15
JO - Giordania 15
TW - Taiwan 15
UY - Uruguay 15
TN - Tunisia 14
UZ - Uzbekistan 14
CH - Svizzera 13
ET - Etiopia 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
NP - Nepal 11
AL - Albania 10
KZ - Kazakistan 10
NG - Nigeria 9
RS - Serbia 9
SN - Senegal 8
OM - Oman 7
CR - Costa Rica 6
PA - Panama 6
AZ - Azerbaigian 5
GR - Grecia 5
JM - Giamaica 5
KW - Kuwait 5
LB - Libano 5
BO - Bolivia 4
MO - Macao, regione amministrativa speciale della Cina 4
MT - Malta 4
PT - Portogallo 4
RO - Romania 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
GA - Gabon 3
HU - Ungheria 3
AO - Angola 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
LI - Liechtenstein 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
Totale 25.395
Città #
Dublin 2.279
Hong Kong 1.254
Jacksonville 1.253
Singapore 1.009
San Jose 696
Ashburn 667
Beijing 462
Lauterbourg 371
Ho Chi Minh City 339
Moscow 292
Lawrence 281
Princeton 281
Wilmington 279
Hanoi 267
Los Angeles 260
Buffalo 174
Cotonou 170
Seoul 128
São Paulo 116
New York 106
Munich 105
Novara 99
Milan 95
Orem 89
Redondo Beach 85
Chandler 82
Brno 72
Santa Clara 70
Warsaw 68
Tianjin 67
Dallas 63
Frankfurt am Main 63
San Mateo 62
Da Nang 56
Ann Arbor 55
Chennai 55
Nuremberg 55
Falkenstein 53
Rome 53
Haiphong 52
Bremen 48
Tokyo 48
Johannesburg 47
London 46
Houston 45
Turin 44
Denver 40
Helsinki 40
Amsterdam 39
Chicago 39
Montreal 38
Piemonte 38
St Louis 38
Brooklyn 37
Vercelli 37
Guangzhou 36
Toronto 36
Atlanta 35
Mexico City 35
Vienna 35
Mülheim 32
Poplar 30
Rio de Janeiro 30
Brussels 29
Phoenix 29
Norwalk 27
Shanghai 27
New Delhi 26
Shenzhen 26
Baghdad 25
Seattle 25
Stockholm 25
Assago 24
Boston 23
Council Bluffs 23
Guayaquil 23
Jakarta 23
Ankara 22
Boardman 22
Curitiba 22
Mumbai 22
Porto Alegre 22
San Francisco 22
Fairfield 21
Manchester 20
Torino 20
West Jordan 20
Brasília 19
Dhaka 18
Nairobi 18
Belo Horizonte 17
Paris 17
Turku 17
Hangzhou 16
Hải Dương 16
Ninh Bình 16
Quito 16
Biên Hòa 15
Buenos Aires 15
Elk Grove Village 15
Totale 13.759
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 371
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 174
Change over time of COVID-19 hospital presentation in Northern Italy 162
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 155
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 155
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 152
Strike early–strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry 151
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 141
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 137
One-Year Follow up of Noninvasive Respiratory Support in General Wards 137
Dieci quesiti in tema di test da sforzo cardiopolmonare: tutto quello che il cardiologo osa e non osa chiedere 135
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 133
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 123
A nurse-led coaching intervention with home telemonitoring for patients with heart failure: Protocol for a feasibility randomized clinical trial 122
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 122
Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis 121
Metabolomics diagnosis of covid-19 from exhaled breath condensate 120
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 117
Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases 114
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 106
Reduction of admissions for urgent and elective pacemaker implant during the COVID-19 outbreak in Northern Italy 106
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 105
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 103
Safety and Efficacy of Different Antithrombotic Strategies After Transcatheter Aortic Valve Implantation: A Network Meta-Analysis 103
Characterization of Circulating Vesicles of Complicated and Uncomplicated Systemic Sclerosis Patients and Their Role in Vascular Dysfunction 100
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 100
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 98
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study * 98
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 98
Kounis Syndrome: an underestimated emergency 96
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 96
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 95
Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention 95
[Proposal for a diagnostic and therapeutic care pathway of the Piedmont Region on lipid-lowering and antithrombotic treatment in patients with peripheral arterial disease] 94
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 94
[Zero-fluoroscopy transcatheter ablation and CRT-D implantation: new frontiers of electroanatomical mapping systems] 92
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak 92
Causes of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: findings from the SYNCOPACED registry 92
Unmasking of a significant left main stenosis in a patient with high left ventricular pressures 91
Left bundle branch area pacing (LBBAP) Auto Threshold algorithms Evaluation for Conduction System Pacing: The LATECS pilot Trial 90
A clinical-in silico study on the effectiveness of multipoint bicathodic and cathodic-anodal pacing in cardiac resynchronization therapy 90
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 89
Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation 88
Clustering of blood cell count abnormalities and future risk of death 88
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 88
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology 87
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 87
Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registry 86
Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials 86
Atrio-ventricular block in a young patient with multisystemic c-antineutrophilic cytoplasmic antibody vasculitis with myocardial involvement: a case report 86
Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients 86
Risk of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: Role of correlation between symptoms and electrocardiogram findings 86
Left Atrial Strain to Predict Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting 85
Infective endocarditis complicating COVID-19 pneumonia: a case report 85
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 84
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning 83
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 82
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 82
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak 82
Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation 81
Speckle Tracking Echocardiography: Early Predictor of Diagnosis and Prognosis in Coronary Artery Disease 81
Terapie antitrombotiche in pazienti con infezione da SARS-CoV-2: Dalle attuali evidenze alle ragionevoli raccomandazioni – Position paper del gruppo di studio aterosclerosi, trombosi e biologia vascolare 81
New echocardiographic indices of shift to biventricular failure to optimize risk stratification of chronic heart failure 81
Impact of a personalized, strike early and strong lipid-lowering approach on low-density lipoprotein-cholesterol levels and cardiovascular outcome in patients with acute myocardial infarction 80
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 80
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry 80
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 79
COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications 79
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 79
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 79
Rate and nature of complications of conduction system pacing compared with right ventricular pacing: Results of a propensity score-matched analysis from a multicenter registry 78
Coronary sinus for cardiac resynchronization therapy: leave it alone and go for the branch! a case report 78
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 78
Arrhythmic Risk Stratification and Sudden Cardiac Death Prevention in Duchenne Muscular Dystrophy: A Critical Appraisal 78
Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches 78
Management of patients explanted for implantable cardioverter defibrillator infections: Bridge therapy with external temporary ICD 78
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 78
A case report of long COVID-19 and chronic active myocarditis 77
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 77
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 77
Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention A Collaborative Patient-Level Meta-Analysis of 13 Randomized Studies 77
Prevention of ischaemic events in subjects with polydistrict vascular disease 77
Usefulness of a multiparametric evaluation including global longitudinal strain for an early diagnosis of acute myocarditis 77
Electrical storm treatment by percutaneous stellate ganglion block: the STAR study 76
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial) 76
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 76
Percutaneous coronary interventions and statin therapy 76
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 76
[Concepts and preconceptions on the use of direct oral anticoagulants in Italy: a Delphi consensus panel of the Atherosclerosis Thrombosis, Vascular Biology Study Group (ATBV)] 76
Updated antithrombotic strategies to reduce the burden of cardiovascular recurrences in patients with chronic coronary syndrome 76
Impact of a personalized, strike early and strong approach on non-HDL-cholesterol levels and outcome in patients with acute myocardial infarction 75
Embolia polmonare a rischio intermedio-alto: il tempo conta. Il caso di una giovane donna in allattamento 74
The Non-Invasive Diagnosis of Chronic Coronary Syndrome: A Focus on Stress Computed Tomography Perfusion and Stress Cardiac Magnetic Resonance 74
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 74
Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR 73
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment 73
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 73
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study 73
Totale 9.963
Categoria #
all - tutte 151.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 0 0 0 0 31 264 15
2021/20221.266 56 34 64 91 72 22 43 49 147 72 242 374
2022/20233.291 327 108 144 30 93 127 79 98 2.083 22 133 47
2023/20241.577 78 79 80 45 307 38 217 63 68 77 100 425
2024/20253.992 102 22 141 43 85 258 414 389 1.174 474 157 733
2025/202613.285 598 520 1.087 2.085 1.182 1.073 2.100 2.543 1.169 928 0 0
Totale 26.156